Related references
Note: Only part of the references are listed.Discovery of novel antagonists targeting the DNA binding domain of androgen receptor by integrated docking-based virtual screening and bioassays
Jin-ping Pang et al.
ACTA PHARMACOLOGICA SINICA (2022)
The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response
Jacob E. Berchuck et al.
CANCER RESEARCH (2022)
Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potential
Jeroen Kneppers et al.
NATURE COMMUNICATIONS (2022)
Development of Novel Inhibitors Targeting the D-Box of the DNA Binding Domain of Androgen Receptor
Mariia Radaeva et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
A noncanonical AR addiction drives enzalutamide resistance in prostate cancer
Yundong He et al.
NATURE COMMUNICATIONS (2021)
Reviewing the toolbox for degrader development in oncology
Joel O. Cresser-Brown et al.
CURRENT OPINION IN PHARMACOLOGY (2021)
Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 Inhibitors
Andre Richters et al.
CELL CHEMICAL BIOLOGY (2021)
Differential modulation of the androgen receptor for prostate cancer therapy depends on the DNA response element
Steven Kregel et al.
NUCLEIC ACIDS RESEARCH (2020)
Ralaniten Sensitizes Enzalutamide-Resistant Prostate Cancer to Ionizing Radiation in Prostate Cancer Cells that Express Androgen Receptor Splice Variants
Carmen A. Banuelos et al.
CANCERS (2020)
Sequence specific suppression of androgen receptor-DNA binding in vivo by a Py-Im polyamide
Alexis A. Kurmis et al.
NUCLEIC ACIDS RESEARCH (2019)
Factors that influence the androgen receptor cistrome in benign and malignant prostate cells
Ben T. Copeland et al.
MOLECULAR ONCOLOGY (2019)
Molecules targeting the androgen receptor (AR) signaling axis beyond the AR-Ligand binding domain
N. G. R. Dayan Elshan et al.
MEDICINAL RESEARCH REVIEWS (2019)
Targeting Proteotoxic Stress in Cancer: A Review of the Role that Protein Quality Control Pathways Play in Oncogenesis
Matthew Ho Zhi Guang et al.
CANCERS (2019)
Stabilization of the Max Homodimer with a Small Molecule Attenuates Myc-Driven Transcription
Nicholas B. Struntz et al.
CELL CHEMICAL BIOLOGY (2019)
A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer
David Y. Takeda et al.
CELL (2018)
Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer
Maha Hussain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Androgen receptor splice variants bind to constitutively open chromatin and promote abiraterone-resistant growth of prostate cancer
Yundong He et al.
NUCLEIC ACIDS RESEARCH (2018)
Selectively targeting the dimerization interface of human androgen receptor with small-molecules to treat castration-resistant prostate cancer
Kush Dalal et al.
CANCER LETTERS (2018)
ZFX Mediates Non-canonical Oncogenic Functions of the Androgen Receptor Splice Variant 7 in Castrate-Resistant Prostate Cancer
Ling Cai et al.
MOLECULAR CELL (2018)
Integrative epigenetic taxonomy of primary prostate cancer
Suzan Stelloo et al.
NATURE COMMUNICATIONS (2018)
The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy
Martin Puhr et al.
CLINICAL CANCER RESEARCH (2018)
Bypassing Drug Resistance Mechanisms of Prostate Cancer with Small Molecules that Target Androgen Receptor-Chromatin Interactions
Kush Dalal et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4
Xiangpeng Dai et al.
NATURE MEDICINE (2017)
Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer
Alfonso Urbanucci et al.
CELL REPORTS (2017)
Pharmacologic Targeting of Chromatin Modulators As Therapeutics of Acute Myeloid Leukemia
Rui Lu et al.
FRONTIERS IN ONCOLOGY (2017)
Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic
Yusuke Imamura et al.
INTERNATIONAL JOURNAL OF UROLOGY (2016)
BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer
Irfan A. Asangani et al.
MOLECULAR CANCER RESEARCH (2016)
FOXA1 acts upstream of GATA2 and AR in hormonal regulation of gene expression
J. C. Zhao et al.
ONCOGENE (2016)
Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer
Emmanuel S. Antonarakis et al.
ONCOLOGIST (2016)
Androgen Receptor Splice Variants Dimerize to Transactivate Target Genes
Duo Xu et al.
CANCER RESEARCH (2015)
Rechallenge of docetaxel combined with epirubicin given on a weekly schedule in advanced castration-resistant prostate cancer patients previously exposed to docetaxel and abiraterone acetate: a single-institution experience
R. Petrioli et al.
MEDICAL ONCOLOGY (2015)
The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis
Mark M. Pomerantz et al.
NATURE GENETICS (2015)
NAR Breakthrough Article Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies
Siu Chiu Chan et al.
NUCLEIC ACIDS RESEARCH (2015)
Phthalimide conjugation as a strategy for in vivo target protein degradation
Georg E. Winter et al.
SCIENCE (2015)
Androgen receptor: structure, role in prostate cancer and drug discovery
M. H. Eileen Tan et al.
ACTA PHARMACOLOGICA SINICA (2015)
Agonist and antagonist switch DNA motifs recognized by human androgen receptor in prostate cancer
Zhong Chen et al.
EMBO JOURNAL (2015)
Recent discoveries and applications involving small-molecule microarrays
Jiyoung A. Hong et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2014)
Selectively Targeting the DNA-binding Domain of the Androgen Receptor as a Prospective Therapy for Prostate Cancer
Kush Dalal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Looking at nuclear receptors from a new angle
Christine Helsen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
A Small Molecule That Binds and Inhibits the ETV1 Transcription Factor Oncoprotein
Marius S. Pop et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
Irfan A. Asangani et al.
NATURE (2014)
Androgen receptor uses relaxed response element stringency for selective chromatin binding and transcriptional regulation in vivo
Biswajyoti Sahu et al.
NUCLEIC ACIDS RESEARCH (2014)
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
Gang Lu et al.
SCIENCE (2014)
Glucocorticoid Receptor Activity Contributes to Resistance to Androgen-Targeted Therapy in Prostate Cancer
Masis Isikbay et al.
HORMONES & CANCER (2014)
The Androgen Receptor Induces a Distinct Transcriptional Program in Castration-Resistant Prostate Cancer in Man
Naomi L. Sharma et al.
CANCER CELL (2013)
In vitro model systems to study androgen receptor signaling in prostate cancer
Natalie Sampson et al.
ENDOCRINE-RELATED CANCER (2013)
An androgen receptor N-terminal domain antagonist for treating prostate cancer
Jae-Kyung Myung et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Animal Toxicity of Hairpin Pyrrole-lmidazole Polyamides Varies with the Turn Unit
Fei Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Characterization and Solubilization of Pyrrole-Imidazole Polyamide Aggregates
Amanda E. Hargrove et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Structural basis for nuclear hormone receptor DNA binding
Christine Helsen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Small Molecule Inhibitors Targeting the Achilles' Heel of Androgen Receptor Activity
Marianne D. Sadar
CANCER RESEARCH (2011)
Comprehensive Genome-wide Protein-DNA Interactions Detected at Single-Nucleotide Resolution
Ho Sung Rhee et al.
CELL (2011)
Intratumoral androgen biosynthesis in prostate cancer pathogenesis and response to therapy
Changmeng Cai et al.
ENDOCRINE-RELATED CANCER (2011)
Alternatively spliced androgen receptor variants
Scott M. Dehm et al.
ENDOCRINE-RELATED CANCER (2011)
Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA
Dong Wang et al.
NATURE (2011)
Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription
Feng Zhang et al.
NATURE BIOTECHNOLOGY (2011)
An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression
Jindan Yu et al.
CANCER CELL (2010)
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
Shihua Sun et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
The Rules of DNA Recognition by the Androgen Receptor
Sarah Denayer et al.
MOLECULAR ENDOCRINOLOGY (2010)
Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
Philip A. Watson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
Zhiyong Guo et al.
CANCER RESEARCH (2009)
Non-competitive androgen receptor inhibition in vitro and in vivo
Jeremy O. Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion
William P. Harris et al.
NATURE CLINICAL PRACTICE UROLOGY (2009)
Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomics
Ashley R. Schneekloth et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
Scott M. Dehm et al.
CANCER RESEARCH (2008)
New androgen receptor genomic targets show an interaction with the ETS1 transcription factor
Charles E. Massie et al.
EMBO REPORTS (2007)
A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth
Qianben Wang et al.
MOLECULAR CELL (2007)
Completion of a programmable DNA-binding small molecule library
Carey F. Hsu et al.
TETRAHEDRON (2007)
Suppression of androgen receptor-mediated gene expression by a sequence-specific DNA-binding polyamide
Nicholas G. Nickols et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Loss of androgen receptor binding to selective androgen response elements causes a reproductive phenotype in a knockin mouse model
Kris Schauwaers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Structural basis for accommodation of nonsteroidal ligands in the androgen receptor
CE Bohl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Structural basis for antagonism and resistance of bicalutamide in prostate cancer
CE Bohl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Small molecule microarrays: recent advances and applications
M Uttamchandani et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2005)
Structural basis of androgen receptor binding to selective androgen response elements
PL Shaffer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Recognition of the DNA minor groove by pyrrole-imidazole polyamides
PB Dervan et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2003)
Share Paper
